Login
$PMVP
$1.25 +$0.12 (10.62%) Close

Company Executives

$PMVP Management Team

Mr. Robert Ticktin

Chief Operating Officer

General Counsel

Age 63
Compensation -
Sex Male

Dr. Richard Heyman

Independent Chairman of the Board

Age 67
Compensation $177.5K USD
Sex Male

Dr. David Mack

President

Chief Executive Officer

Co-Founder

Director

Age 63
Compensation $4.760M USD
Sex Male

Mr. Michael Carulli

Chief Financial Officer

Age 51
Compensation $1.380M USD
Sex Male

Ms. Deepika Jalota

Chief Development Officer

Age 49
Compensation $1.929M USD
Sex Female
Directors
5
serving now
Independent
5 of 5
stated in the proxy
Average tenure
Not stated
from year joined
CEO also chairs the board
Not stated
no chair stated
Director Age On board Independent Committees Other public boards Pay Source
Stelzer
Not stated Not stated Independent
audit · Chair compensation
None stated Not stated
Flowers
Not stated Not stated Independent
audit
None stated Not stated
Heyman Leaving at the meeting
Not stated Not stated Independent
audit compensation · Chair nominating and corporate governance
None stated Not stated
Gallagher
Not stated Not stated Independent
nominating and corporate governance
None stated Not stated
Baum
Not stated Not stated Independent
compensation nominating and corporate governance · Chair
None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

4 disclosed in the proxy filed Apr 22, 2026
Arnold Levine, Ph.D.
one of our co-founders and a member of our board of directors
$100,000
annual

Consulting and advisory services arrangement, with an annual cash payment to Dr. Levine; he also serves on the SAB.

Richard Heyman, Ph.D.
chairperson of our board of directors
Amount not stated

Service on the Scientific Advisory Board; Dr. Heyman waived his rights to SAB compensation effective September 2021.

Charles M. Baum, M.D., Ph.D.
a member of our board of directors
$100,000
February 2024 to January 2026

Prior consulting agreement for senior clinical advisory services, including chairing the CAB; terminated January 2026.

Charles M. Baum, M.D., Ph.D.
$20,000
annual, effective January 2026

Baum CAB Agreement for continued service as chairperson of the CAB, with an annual cash payment.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support